Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | RSKD | KRT |
|---|---|---|
| Price | $8.05 | $53.38 |
| Change today | ▲ 3.34% | ▼ 0.58% |
| Market cap | $1.06B | $1.06B |
| Return, 3 months | +53.0% | +58.4% |
| Return, year to date | +62.0% | +147.1% |
| Return, 1 year | +72.7% | +145.2% |
| P/E (TTM) | -73.2 | 21.4 |
| P/B | 5.1 | 6.4 |
| P/E percentile vs own 5y | 0th | 89th |
| Dividend yield | – | 3.37% |
| Revenue growth (YoY, latest qtr) | +21.8% | +9.9% |
| Net profit growth (YoY) | +21.7% | +168.3% |
| Gross margin | 51.3% | 40.7% |
| Operating margin | -4.7% | 12.8% |
| Net margin | -4.2% | 10.2% |
| Return on equity | -5.7% | 30.7% |
| Analyst target vs. price | -6.1% | -12.9% |
| Analyst buy share | 60% | 67% |
| RSI (14) | 73 | 63 |
| 30-day volatility | 58.7% | 27.8% |
| Max drawdown, 1 year | -25.4% | -17.4% |
| Trend read | Strong uptrend | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
